ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Serina Therapeutics Inc

Serina Therapeutics Inc (SER)

1.90
0.02
(1.06%)
終了 6月9日 5:00AM
1.79
-0.11
(-5.79%)
取引時間後: 8:56AM

Serina Therapeutics Inc (SER) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
1.79
( -4.79% )
買値
-
売値
-
出来高
60,737
1.8401 日の範囲 1.96
1.22 52 週間の範囲 7.92
時価総額
前日終値
1.88
始値
1.93
最終取引時間
財務取引量
US$ 116,921
VWAP
1.925
平均取引量 (3 か月)
US$ 3,237,438
発行済株式数
14,898,617
配当利回り
PER
-0.93
1 株当たり利益 (EPS)
-2.01
歳入
130k
純利益
-21.27M

Serina Therapeutics Inc について

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson’s disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic ... Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson’s disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigotine for the treatment of early Parkinson’s and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is headquartered in Huntsville, Alabama. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Huntsville, United States
設立
2026
Serina Therapeutics Inc is listed in the Healthcare sector of the アメリカ証券取引所 with ticker SER. The last closing price for Serina Therapeutics was US$1.88. Over the last year, Serina Therapeutics shares have traded in a share price range of US$ 1.22 to US$ 7.92.

Serina Therapeutics currently has 14,898,617 shares in issue. The market capitalisation of Serina Therapeutics is US$26.67 million. Serina Therapeutics has a price to earnings ratio (PE ratio) of -0.93.

SER 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.05-2.717391304351.841.991.7779101.85087342CS
40.084.67836257311.712.031.49968641.77288863CS
120.2516.23376623381.543.291.2234950142.46899726CS
26-1.41-44.06253.24.081.2222967512.72572626CS
52-4.29-70.55921052636.087.921.2211803872.80815142CS
156-9.89-84.674657534211.6819.931.225444242.87605639CS
260-9.89-84.674657534211.6819.931.225444242.87605639CS

SER - Frequently Asked Questions (FAQ)

What is the current Serina Therapeutics Inc share price?
The current share price of Serina Therapeutics Inc is US$ 1.79
How many Serina Therapeutics Inc shares are in issue?
Serina Therapeutics Inc has 14,898,617 shares in issue
What is the market cap of Serina Therapeutics Inc?
The market capitalisation of Serina Therapeutics Inc is USD 26.67M
What is the 1 year trading range for Serina Therapeutics Inc share price?
Serina Therapeutics Inc has traded in the range of US$ 1.22 to US$ 7.92 during the past year
What is the PE ratio of Serina Therapeutics Inc?
The price to earnings ratio of Serina Therapeutics Inc is -0.93
What is the cash to sales ratio of Serina Therapeutics Inc?
The cash to sales ratio of Serina Therapeutics Inc is 215.46
What is the registered address of Serina Therapeutics Inc?
The registered address for Serina Therapeutics Inc is 601 Genome Way, Huntsville, Alabama, 35806
What is the Serina Therapeutics Inc website address?
The website address for Serina Therapeutics Inc is serinatherapeutics.com
Which industry sector does Serina Therapeutics Inc operate in?
Serina Therapeutics Inc operates in the Biotechnology & Life Sciences sector

SER 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock